In this study, we integrated WES and AlloDriver to identify allosteric driver mutations in HNSCC and found that the specific mutation H351Q in β‐glucuronidase (GUSB) was a potential novel molecular mechanism for tumor progression. This evidence concerns the gene GUSB and neoplasm.